As the Director of Safety & Epidemiology team at Carelon Research, Dr. Beachler oversees the execution of pharmacoepidemiology, risk management, and medical product safety and effectiveness studies for a portfolio of industry, academic, and government clients. Dr. Beachler has experience conducting validation studies and utilizing predictive modeling and machine learning methods to develop claims-based algorithms to improve cohort and outcome classification. He has scientific oversight of drug safety studies including post authorization safety studies (PASS), risk evaluation and mitigation strategy (REMS), and post-market requirement (PMR) studies.
Prior to joining Carelon Research, Dr. Beachler was a Cancer Prevention Fellow at the National Cancer Institute, Division of Cancer Epidemiology and Genetics. Dr. Beachler has published dozens of manuscripts in peer-reviewed medical literature. He has presented his work at scientific meetings and to regulatory authorities worldwide.
Follow us on LinkedIn to learn how our leaders are solving today’s most complex health challenges.